Lumipulse® G HE4 (Human epididymis protein 4)

From the company that brought you CA125, Fujirebio now introduces HE4, the first new biomarker in 30 years for ovarian cancer management1

Lumipulse G HE4 is a Chemiluminescent Enzyme Immunoassay (CLEIA) for in vitro diagnostics (IVD) use for the quantitative measurement of HE4 (Human epididymis protein 4) in human serum or plasma (sodium heparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G system.

The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.

    CE marked
    Lumipulse® G HE4 Immunoreaction Cartridges

    Product number 234068

    3 × 14 Tests
    Lumipulse® G HE4 Calibrators

    Product number 234075

    1 × 2 Concentrations
    Contact sales for information and inquiries
    Please contact your local Fujirebio representative for the availability of this product in your country.

    Click here to navigate

    • Details
    • Conditions of sale
    • Documentation
    • Insights
    • Related products
    • Product inquiry
    • Details

      What is HE4?

      Human Epididymis protein 4 (HE4), a serum biomarker, is expressed in normal epithelial tissue. HE4 is detected in high levels in the serum of ovarian cancer patients. HE4 has shown to be a stable biomarker in which levels do not change in normal physiological conditions.

      HE4 is not evelevated

      • during pregnancy2
      • in any phases of the menstruation cycle or with hormonal treatments3
      • with hormonal stimulation during IVF treatment4

      Importance of specific biomarker for management of gynecologic diseases

      Cysts are a common occurrence, especially in premenopausal women, and the majority of cysts are benign:

      • Up to 10% of women will have some form of surgery for ovarian mass5
      • Preoperative differentiation between the benign and the malignant ovarian mass in the premenopausal woman is problematic6


      Assay technology

      CLEIA - ChemiLuminescent Enzyme Immunoassay

      • Broad dynamic assay range: 20.0-1500 pmol/L.
      • LOD: 3.5 pmol/L.
      • Precision (CV): Within run <3,5% and total precision <3,2%.
      • 25 minute incubation time on the LUMIPULSE G1200, 30 minute incubation time on the LUMIPULSE G600II.
      • 30 days calibration stability.
      • Packaging: 42 tests per kit.
      • Unique cartridge concept.

      Test principle: Two-Step sandwich assay



      1. Diamandis E, et al. Cancer Biomarkers: Can we turn recent failures into success? Cancer Inst. 2010; 102;1-6.
      2. Moore RG, Miller MC, Eklund EE, et al. Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age. Am J Obstet Gynecol. 2012;206(4):349.E1-7.

      3. Hallamaa M, Suvitie P, Huhtinen K, et al. Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women. Gynecol Oncol. 2012;125(3):667-72.

      4. Hallamaa M, Huhtinen K, Suvitie P, Perheentupa A. Serum concentrations of HE4 change little during in vitro fertilization. Acta Obstet Gynecol Scand. 2014 Apr 15. doi: 10.1111/aogs.12393. [Epub ahead of print]

      5. Hilger WS, Magrina JF, Magtibay PM. Laparoscopic management of the adnexal mass. Clin Obstet Gynecol. 2006;49:535-548).

      6. Green-top Guideline No. 62, RCOG/BSGE Joint Guideline | November 2011


      See the LUMIPULSE G1200 working in this video:



    • Conditions of sale

      To read the end user conditions of sale for this product please visit our Resource center.

    • Insights

    • Product inquiry

      The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

      For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

      If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: